For example, it is necessary to confirm changes in the expression levels of thyroid hormone or AF-related stroke diagnostic biomarkers, such as TTR by obtaining samples at several time points, such as before stroke occurrence in patients with AF, at occurrence, after occurrence, and after recovery. This evidence concerns the gene TTR and stroke disorder.